FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000MG1SNR4

Market Closed - Börse Stuttgart 12:35:51 08/06/2024 am IST
10.85 EUR -1.45% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-1.27%
1 month-1.72%
Date Price Change
07/24/07 10.85 -1.45%
06/24/06 11.01 -1.17%
05/24/05 11.14 +2.77%
04/24/04 10.84 +1.40%
03/24/03 10.69 -2.73%

Delayed Quote Börse Stuttgart

Last update June 08, 2024 at 12:35 am IST

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer Morgan Stanley
WKN MG1SNR
ISINDE000MG1SNR4
Date issued 05/04/2024
Strike 195.2 $
Maturity Unlimited
Parity 4.07 : 1
Emission price 10
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 12.43
Lowest since issue 9.63
Spread 0.01
Spread %0.09%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.1 USD
Average target price
171.7 USD
Spread / Average Target
+16.75%
Consensus